Literature DB >> 1649707

Low-dose methotrexate therapy for hepatoblastoma.

S D Weitman, G J Kato, J L Barbosa, B A Kamen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649707     DOI: 10.1007/bf00685519

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  11 in total

1.  TRIPLE DRUG THERAPY WITH ACTINOMYCIN D (NSC-3053), CHLORAMBUCIL (NSC-3088), AND METHOTREXATE (NSC-740) IN METASTATIC SOLID TUMORS IN CHILDREN.

Authors:  B K FISHER; G B ELLIOTT
Journal:  Cancer Chemother Rep       Date:  1965-04

2.  Combination chemotherapy in the treatment of hepatoblastoma.

Authors:  A Staines; S Cullen; E J Guiney; R J Fitzgerald; F Breatnach
Journal:  Pediatr Hematol Oncol       Date:  1990       Impact factor: 1.969

3.  Combination chemotherapy with 5-fluorouracil (NSC-19893), methotrexate (NSC-740), and prednisolone (NSC-9900) (FAP protocol) for hepatoma.

Authors:  T Umsawasdi; T Chainuvati; S Hitannant; P Nilprabhassorn; V Viranuvatti
Journal:  Cancer Chemother Rep       Date:  1975 Nov-Dec

4.  Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.

Authors:  A M Cochrane; I M Murray-Lyon; D M Brinkley; R Williams
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

5.  Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate.

Authors:  N J Winick; B A Kamen; F M Balis; J Holcenberg; C M Lester; D G Poplack
Journal:  Cancer Drug Deliv       Date:  1987

6.  Infusion chemotherapy in hepatoma and metastatic liver tumors.

Authors:  B Gorgun; A L Watne
Journal:  Am J Surg       Date:  1967-03       Impact factor: 2.565

7.  Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker.

Authors:  J Hendel; H Brodthagen
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.

Authors:  T Kanematsu; Y Maehara; T Kusumoto; K Sugimachi
Journal:  Eur J Cancer Clin Oncol       Date:  1988-09

9.  Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma.

Authors:  A E Evans; V J Land; W A Newton; J G Randolph; H N Sather; M Tefft
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

10.  Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.

Authors:  B A Kamen; P A Nylen; B M Camitta; J R Bertino
Journal:  Br J Haematol       Date:  1981-11       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.